MX2017002584A - Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto. - Google Patents

Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto.

Info

Publication number
MX2017002584A
MX2017002584A MX2017002584A MX2017002584A MX2017002584A MX 2017002584 A MX2017002584 A MX 2017002584A MX 2017002584 A MX2017002584 A MX 2017002584A MX 2017002584 A MX2017002584 A MX 2017002584A MX 2017002584 A MX2017002584 A MX 2017002584A
Authority
MX
Mexico
Prior art keywords
composition
product
body weight
body fat
reducing
Prior art date
Application number
MX2017002584A
Other languages
English (en)
Inventor
Ling Yu-Fang
Original Assignee
Caliway Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caliway Biopharmaceuticals Co Ltd filed Critical Caliway Biopharmaceuticals Co Ltd
Publication of MX2017002584A publication Critical patent/MX2017002584A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición y un producto medicinal para reducir el peso corporal y la grasa corporal y el uso del dicho producto. La composición contiene un extracto de té verde y un extracto turmérico, los porcentajes en peso de extracto de té verde y del extracto turmérico son, respectivamente, 30% a 75% y 20% a 55% del peso total de la composición. En pruebas en animales en donde se indujo obesidad ya sea antes o durante la prueba, el uso de la composición de la presente invención genera una reducción más significativa del peso corporal y la grasa corporal que cuando se utiliza únicamente un extracto de planta o el medicamento reductor de obesidad disponible comercialmente, Qrlistat.
MX2017002584A 2014-08-28 2015-08-28 Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto. MX2017002584A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462042955P 2014-08-28 2014-08-28
PCT/CN2015/088338 WO2016029868A1 (zh) 2014-08-28 2015-08-28 用于减少体重及减少体脂肪的组合物及其医药品与应用

Publications (1)

Publication Number Publication Date
MX2017002584A true MX2017002584A (es) 2017-05-25

Family

ID=55398770

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002584A MX2017002584A (es) 2014-08-28 2015-08-28 Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto.

Country Status (11)

Country Link
US (1) US10537605B2 (es)
EP (1) EP3187189B1 (es)
JP (1) JP6446552B2 (es)
KR (1) KR101923840B1 (es)
CN (1) CN106794215A (es)
AU (2) AU2015309351B2 (es)
CA (1) CA2960075C (es)
ES (1) ES2851680T3 (es)
MX (1) MX2017002584A (es)
TW (1) TWI580427B (es)
WO (1) WO2016029868A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226503B2 (en) 2014-08-28 2019-03-12 Caliway Biopharmaceuticals Co., Ltd. Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof
ES2924879T3 (es) 2014-08-28 2022-10-11 Caliway Biopharmaceuticals Co Ltd Composición y productos farmacéuticos para reducir la grasa localizada y el peso corporal y su uso
US10537548B2 (en) 2014-08-28 2020-01-21 Caliway Biopharmaceuticals Co., Ltd. Composition and medical product for reducing body weight and body fat, and use of said product
EP3381473A4 (en) * 2015-08-28 2019-10-09 Caliway Biopharmaceuticals Co., Ltd. PHARMACEUTICAL COMPOSITION FOR REDUCING LOCALIZED FAT AND USE OF THE PHARMACEUTICAL COMPOSITION
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
CN110446492A (zh) * 2017-03-28 2019-11-12 康霈生技股份有限公司 用于减少体重及减少体脂肪的组合物及其医药品与应用
WO2020202193A1 (en) * 2019-03-31 2020-10-08 Jeyakodi Shankaranarayanan Synergistic combination of phytoactives
KR102137136B1 (ko) * 2019-11-29 2020-08-13 주식회사 어바웃굿즈 호박 가수분해 추출물, 구약감자 가수분해 추출물, 강황 추출물 및 카카오닙스 추출물을 포함하는 조성물
KR20220147743A (ko) 2021-04-27 2022-11-04 강원대학교산학협력단 감마폴리글루탐산 및 레반의 혼합물을 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물
KR20230114107A (ko) * 2022-01-24 2023-08-01 연세대학교 산학협력단 심혈관계 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475530B1 (en) * 2000-05-31 2002-11-05 Eric H. Kuhrts Methods and compositions for producing weight loss
US7396546B2 (en) * 2001-08-06 2008-07-08 The Quigley Corporation Anti-microbial compositions and methods of using same
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US7030092B1 (en) * 2001-08-24 2006-04-18 Small Giant L.L.C. Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.
US20060172012A1 (en) * 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
US7744931B2 (en) 2005-06-14 2010-06-29 New Chapter Inc. Methods for treating oral cancers with herbal compositions
WO2007041276A2 (en) * 2005-09-29 2007-04-12 New Chapter, Inc. Methods for modulating apoptosis, cellgrowth, and protein expression with herbal compositions
US7977319B1 (en) * 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
CN101095665A (zh) 2006-06-27 2008-01-02 中国科学院上海生命科学研究院 Sirt1在预防、控制或治疗肥胖中的用途
US8192768B2 (en) 2007-04-03 2012-06-05 Laila Impex Synergistic anti-inflammatory and antioxidant dietary supplement compositions
CN102357226B (zh) * 2007-08-07 2013-07-10 北京北大维信生物科技有限公司 中草药姜黄的醇提取物在制备具有脂肪酶活性抑制作用的药物中的应用
US20090239943A1 (en) * 2008-03-19 2009-09-24 Sarkar Fazlul H Nutraceutical composition and methods for its use
EP2348868A4 (en) * 2008-10-22 2013-06-12 Metaproteomics Llc NOVEL METHODS OF MITOCHONDRIAL DECOUPLING AND COMPOSITIONS FOR INCREASING ADIPOCYTE THERMOGENESIS
CN101632655B (zh) * 2009-08-04 2011-12-07 南京大渊美容保健有限公司 延缓衰老的白藜芦醇和生物类黄酮营养组合物
CN101695324B (zh) * 2009-09-21 2012-07-25 杭州六易科技有限公司 一种调节血脂的降脂茶的制作方法
JP2012044982A (ja) * 2010-08-26 2012-03-08 Miyazaki Mokuzaiten:Kk 健康茶
US8815310B2 (en) 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
AU2012287067B2 (en) 2011-07-25 2016-12-08 Dermaforce Holdings, LLC Botanical antioxidant compositions and methods of preparation and use thereof
WO2014028607A1 (en) 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics
US9211298B2 (en) * 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
US20140287071A1 (en) * 2013-01-17 2014-09-25 Lifevantage Corporation Veterinary supplements
CN103479972B (zh) * 2013-09-29 2015-08-26 四川大学华西医院 一种用于抗氧化的组合物及其制备方法和用途

Also Published As

Publication number Publication date
KR20170044196A (ko) 2017-04-24
EP3187189B1 (en) 2020-11-18
TWI580427B (zh) 2017-05-01
JP2017525771A (ja) 2017-09-07
US20170157194A1 (en) 2017-06-08
AU2015309351B2 (en) 2019-01-03
KR101923840B1 (ko) 2019-02-27
AU2018278907B2 (en) 2020-08-13
AU2018278907A1 (en) 2019-01-03
EP3187189A1 (en) 2017-07-05
CA2960075A1 (en) 2016-03-03
CN106794215A (zh) 2017-05-31
US10537605B2 (en) 2020-01-21
EP3187189A4 (en) 2018-04-11
TW201707722A (zh) 2017-03-01
ES2851680T3 (es) 2021-09-08
WO2016029868A1 (zh) 2016-03-03
JP6446552B2 (ja) 2018-12-26
AU2015309351A1 (en) 2017-03-30
CA2960075C (en) 2021-02-09

Similar Documents

Publication Publication Date Title
MX2017002584A (es) Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto.
MX2017008813A (es) Polvo de coleopteros.
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
ZA202103074B (en) Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation
MX2017008815A (es) Composicion que contiene quitina y proteinas digeribles.
MX2016016871A (es) Metodo para mejorar el valor nutricional de pienso para animales.
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
EA033540B1 (ru) Композиция, включающая окру, для применения в уменьшении абсорбции пищевого жира
MX2018008645A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018008643A (es) Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano.
HUE059878T2 (hu) Készítmény és gyógyszerek lokális zsír és testtömeg csökkentésére és ezek alkalmazása
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2017001632A (es) Mioinositol y probioticos, y uso de estos.
MY177827A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
IL251687B (en) Medicinal composition for use in treatment to prevent vitamin and mineral deficiencies in patients who have undergone gastric bypass surgery
PH12016501205A1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
SG11201701939UA (en) Cosmetic and/or pharmaceutical composition in the form of a dispersion, method for preparing same and use thereof for skin treatment
MX2016016021A (es) Composicion farmaceutica para prevenir y tratar la demencia senil y su metodo de preparacion.
MY192535A (en) Method of using cistanche tubulosa extract for preparing drugs or food to protect eye cells
MX360885B (es) Nuevas composiciones antifungicas.
HUP1400235A2 (en) Process and use of cosmetic composition comprising natural, bilogically actine ingredient for benefitial and economical use
NZ784118A (en) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2017007990A (es) Métodos para reducir la agregación plaquetaria y tratar enfermedades cardiovasculares y otros transtornos médicos.